FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089852149> ?p ?o ?g. }

• W3089852149 endingPage "151076" @default.
• W3089852149 startingPage "151076" @default.
• W3089852149 abstract "The purpose of this systematic review and meta-analysis was to evaluate the safety (adverse events), feasibility (recruitment, retention, and adherence) and effectiveness of exercise among individuals with lung cancer. Electronic databases (CINAHL, Cochrane, Ebscohost, MEDLINE, Pubmed, ProQuest Health and Medical Complete, ProQuest Nursing and Allied Health Source, Science Direct, and SPORTDiscus) were searched for randomized, controlled, exercise trials involving individuals with lung cancer that were published prior to May 1, 2020. The PEDro scale was used to assess risk of bias, and the Common Terminology Criteria for Adverse Events was used to classify adverse event severity. Feasibility was assessed by computing median (range) recruitment, retention, and exercise attendance rates. Meta-analyses were performed to evaluate adverse event risk between exercise and usual care, and effects on health outcomes. Subgroup effects for exercise mode, supervision, intervention duration, diagnosis or treatment-related factors, and trial quality were assessed. Thirty-two trials (n=2109) involving interventions ranging between 1 and 20 weeks were included. Interventions comprised of aerobic (n=13, 41%), resistance (n=1, 3%), combined aerobic and resistance (n=16, 50%) and other exercise (n=2, 6%). There was no difference in the risk of an adverse event between exercise and usual care groups (exercise: n=64 events; usual care: n=61 events]; risk difference: -0.01 [91% CI = -0.02, 0.01]; P = .31). Median recruitment rate was 59% (9%–97%), retention rate was 86% (50%–100%), and adherence rate was 80% (44%–100%). Significant effects of exercise compared to usual care were observed for quality of life, aerobic fitness, upper-body strength, lower-body strength, anxiety, depression, forced expiratory volume, and sleep (standardized mean difference range=0.20–0.59). Subgroup analyses showed that safety, feasibility, and effect was similar irrespective of exercise characteristics, stage at diagnosis, treatment (surgery and chemotherapy), and trial quality. For individuals with lung cancer (stages I–IV), the risk of an adverse event with exercise is low. Exercise can be feasibly undertaken post-diagnosis and leads to improvements in health-related outcomes. Together, these findings add weight behind the importance of integrating exercise into standard cancer care, including for this specific cancer type. Exercise should be considered as part of the treatment for all patients with lung cancer at any stage. Exercise has been shown to be low risk and can be feasibly undertaken by patients. The ideal mode, intensity, frequency, or duration of exercise for all patients with lung cancer is not known. Nonetheless, these findings support endorsement of cancer-specific physical activity guidelines, as well as referral to an exercise professional, such as an exercise physiologist or physiotherapist, for those diagnosed with lung cancer." @default.
• W3089852149 created "2020-10-08" @default.
• W3089852149 creator A5016501396 @default.
• W3089852149 creator A5045556633 @default.
• W3089852149 creator A5074444404 @default.
• W3089852149 creator A5077272052 @default.
• W3089852149 creator A5082346903 @default.
• W3089852149 date "2020-10-01" @default.
• W3089852149 modified "2023-10-18" @default.
• W3089852149 title "Exercise for Individuals With Lung Cancer: A Systematic Review and Meta-Analysis of Adverse Events, Feasibility, and Effectiveness" @default.
• W3089852149 cites W1528685253 @default.
• W3089852149 cites W1561379059 @default.
• W3089852149 cites W1757407923 @default.
• W3089852149 cites W1874985788 @default.
• W3089852149 cites W1968813769 @default.
• W3089852149 cites W1975053426 @default.
• W3089852149 cites W1975993487 @default.
• W3089852149 cites W1978727898 @default.
• W3089852149 cites W1979981013 @default.
• W3089852149 cites W1980701503 @default.
• W3089852149 cites W1981351862 @default.
• W3089852149 cites W1983528762 @default.
• W3089852149 cites W1987957871 @default.
• W3089852149 cites W2000394857 @default.
• W3089852149 cites W2009833418 @default.
• W3089852149 cites W2010894352 @default.
• W3089852149 cites W2012863846 @default.
• W3089852149 cites W2013687346 @default.
• W3089852149 cites W2019606904 @default.
• W3089852149 cites W2020139609 @default.
• W3089852149 cites W2055156085 @default.
• W3089852149 cites W2058032927 @default.
• W3089852149 cites W2060835564 @default.
• W3089852149 cites W2073283330 @default.
• W3089852149 cites W2078552697 @default.
• W3089852149 cites W2082391212 @default.
• W3089852149 cites W2088940783 @default.
• W3089852149 cites W2089678588 @default.
• W3089852149 cites W2093412094 @default.
• W3089852149 cites W2102968146 @default.
• W3089852149 cites W2111722073 @default.
• W3089852149 cites W2113782870 @default.
• W3089852149 cites W2116026204 @default.
• W3089852149 cites W2116690431 @default.
• W3089852149 cites W2120992267 @default.
• W3089852149 cites W2129992678 @default.
• W3089852149 cites W2140914329 @default.
• W3089852149 cites W2153043827 @default.
• W3089852149 cites W2156444894 @default.
• W3089852149 cites W2157823046 @default.
• W3089852149 cites W2159255640 @default.
• W3089852149 cites W2163135056 @default.
• W3089852149 cites W2168323778 @default.
• W3089852149 cites W2168892425 @default.
• W3089852149 cites W2171306475 @default.
• W3089852149 cites W2176214213 @default.
• W3089852149 cites W2205024314 @default.
• W3089852149 cites W2313897333 @default.
• W3089852149 cites W2316041579 @default.
• W3089852149 cites W2524803798 @default.
• W3089852149 cites W2538639798 @default.
• W3089852149 cites W2576458898 @default.
• W3089852149 cites W2587591803 @default.
• W3089852149 cites W2597433966 @default.
• W3089852149 cites W2601868035 @default.
• W3089852149 cites W2605830354 @default.
• W3089852149 cites W2608165270 @default.
• W3089852149 cites W2616310699 @default.
• W3089852149 cites W2741579272 @default.
• W3089852149 cites W2799703080 @default.
• W3089852149 cites W2889646458 @default.
• W3089852149 cites W2894666230 @default.
• W3089852149 cites W2898806190 @default.
• W3089852149 cites W2911188335 @default.
• W3089852149 cites W2915799762 @default.
• W3089852149 cites W2919198539 @default.
• W3089852149 cites W2951648908 @default.
• W3089852149 cites W2979390533 @default.
• W3089852149 cites W3023929354 @default.
• W3089852149 doi "https://doi.org/10.1016/j.soncn.2020.151076" @default.
• W3089852149 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33008682" @default.
• W3089852149 hasPublicationYear "2020" @default.
• W3089852149 type Work @default.
• W3089852149 sameAs 3089852149 @default.
• W3089852149 citedByCount "26" @default.
• W3089852149 countsByYear W30898521492021 @default.
• W3089852149 countsByYear W30898521492022 @default.
• W3089852149 countsByYear W30898521492023 @default.
• W3089852149 crossrefType "journal-article" @default.
• W3089852149 hasAuthorship W3089852149A5016501396 @default.
• W3089852149 hasAuthorship W3089852149A5045556633 @default.
• W3089852149 hasAuthorship W3089852149A5074444404 @default.
• W3089852149 hasAuthorship W3089852149A5077272052 @default.
• W3089852149 hasAuthorship W3089852149A5082346903 @default.
• W3089852149 hasBestOaLocation W30898521491 @default.
• W3089852149 hasConcept C103038586 @default.
• W3089852149 hasConcept C126322002 @default.
• W3089852149 hasConcept C159110408 @default.

• next